Symbol="KRYS"
AssetType="Common Stock"
Name="Krystal Biotech Inc"
Description="Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1711279"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3530068000"
EBITDA="-137116992"
PERatio="None"
PEGRatio="None"
BookValue="23.35"
DividendPerShare="0"
DividendYield="0"
EPS="-5.5"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.137"
ReturnOnEquityTTM="-0.232"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-5.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="148.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.382"
EVToRevenue="-"
EVToEBITDA="-11.46"
Beta="0.81"
num_52WeekHigh="131.8"
num_52WeekLow="61.11"
num_50DayMovingAverage="121.78"
num_200DayMovingAverage="94.07"
SharesOutstanding="27994200"
DividendDate="None"
ExDividendDate="None"
symbol="KRYS"
open="124.06"
high="126.19"
low="121.05"
price="126.10"
volume="182220.00"
latest_trading_day="2023-08-25"
previous_close="124.16"
change="1.94"
change_percent="1.5625%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="12"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="285707"
Change_recent_avg="0.55"
Delta_recent_avg="4.35"
Variance_recent_avg="2.17"
Change_ratio_recent_avg="0.47"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="172"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="689"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
